Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 143.00 USD | -0.49% |
|
-3.50% | +63.73% |
| Market Cap | 9.25B 8.07B 7.62B 6.92B 12.96B 888B 13.02B 91.26B 35.22B 451B 34.76B 33.99B 1,452B | P/E 2026 * |
30.7x | P/E 2027 * | -302x |
|---|---|---|---|---|---|
| Enterprise Value | 8.72B 7.6B 7.18B 6.52B 12.21B 836B 12.26B 85.95B 33.17B 425B 32.74B 32.01B 1,368B | EV / Sales 2026 * |
16.1x | EV / Sales 2027 * | 43x |
| Free-Float |
97.68% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PTGX | Delayed | |
CBOE
| PTGX | Real-time | |
|
Tradegate
| PGF | Real-time |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | -0.49% | ||
| 1 week | -3.50% | ||
| Current month | -3.21% | ||
| 1 month | -9.11% | ||
| 3 months | +26.71% | ||
| 6 months | +47.29% | ||
| Current year | +63.73% |
| 1 week | 140.44 |  | 151.24 |
| 1 month | 140.44 | | 158.08 |
| Current year | 77 | | 160.81 |
| 1 year | 61.95 | | 160.81 |
| 3 years | 13.72 | | 160.81 |
| 5 years | 6.91 | | 160.81 |
| 10 years | 4.47 | | 160.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 30/11/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 17/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 30/11/2008 |
Harold Selick
CHM | Chairman | 71 | 18/03/2014 |
William Waddill
BRD | Director/Board Member | 69 | 30/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/09/26 | Exercice | Chief Executive Officer | 21,834 | 0.0337% | ||
| 03/09/26 | Don | Chief Executive Officer | -510 | 0.0008% | ||
| 11/08/26 | Exercice | Chief Executive Officer | 102,717 | 0.1597% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.49% | -3.50% | +130.13% | +710.20% | 9.25B | |
| +0.11% | +2.71% | +0.33% | +28.59% | 46.28B | |
| -1.12% | +1.78% | +40.07% | +27.26% | 43.85B | |
| -3.04% | -6.29% | +322.27% | +517.36% | 40.93B | |
| -0.74% | +1.25% | +2.32% | +67.94% | 39.9B | |
| -0.50% | +0.67% | +11.79% | +40.51% | 29.5B | |
| -0.46% | +4.22% | +21.99% | +124.21% | 17.09B | |
| -0.97% | -10.17% | - | - | 15.55B | |
| -0.57% | +8.12% | +22.15% | +38.93% | 15.22B | |
| -3.14% | +31.91% | -10.60% | - | 14.05B | |
| Average | -0.94% | +3.04% | +60.05% | +194.37% | 27.16B | |
| Weighted average by Cap. | -1.00% | +1.69% | +67.06% | +152.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 542M 473M 446M 405M 760M 52.03B 763M 5.35B 2.06B 26.45B 2.04B 1.99B 85.12B | 203M 177M 167M 152M 285M 19.52B 286M 2.01B 774M 9.92B 764M 747M 31.93B |
| Net income | 324M 282M 267M 242M 454M 31.07B 455M 3.19B 1.23B 15.79B 1.22B 1.19B 50.82B | -32.12M -28.01M -26.45M -24.02M -45M -3.08B -45.19M -317M -122M -1.57B -121M -118M -5.04B |
| Net Debt | -538M -469M -443M -402M -754M -51.65B -757M -5.31B -2.05B -26.26B -2.02B -1.98B -84.49B | -511M -446M -421M -382M -716M -49.04B -719M -5.04B -1.95B -24.93B -1.92B -1.88B -80.23B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | US$143.00 | -0.49% | 1,837,204 |
| 17/09/26 | US$143.70 | +0.60% | 558,901 |
| 16/09/26 | US$142.84 | -0.39% | 507,311 |
| 15/09/26 | US$143.40 | -2.96% | 637,522 |
| 14/09/26 | US$147.78 | -0.27% | 608,017 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
